Logo image of NMAI

NUVEEN MULTI-ASSET INCOME (NMAI) Stock Overview

USA - NYSE:NMAI - US6707501085

12.86 USD
+0.05 (+0.39%)
Last: 9/29/2025, 4:15:01 PM
Fundamental Rating

2

Taking everything into account, NMAI scores 2 out of 10 in our fundamental rating. NMAI was compared to 0 industry peers in the Unkown industry. NMAI may be in some trouble as it scores bad on both profitability and health. NMAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NMAI had positive earnings in the past year.
NMAI had a positive operating cash flow in the past year.
NMAI Yearly Net Income VS EBIT VS OCF VS FCFNMAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA 5.54%
ROE 8.18%
ROIC 1.51%
ROA(3y)-2.34%
ROA(5y)N/A
ROE(3y)-4.18%
ROE(5y)N/A
ROIC(3y)1.63%
ROIC(5y)N/A
NMAI Yearly ROA, ROE, ROICNMAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

NMAI's Profit Margin has declined in the last couple of years.
NMAI's Operating Margin has declined in the last couple of years.
NMAI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 42.38%
PM (TTM) 124.14%
GM 45.28%
OM growth 3Y-13.98%
OM growth 5YN/A
PM growth 3Y-29.29%
PM growth 5YN/A
GM growth 3Y-15.38%
GM growth 5YN/A
NMAI Yearly Profit, Operating, Gross MarginsNMAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 200 -200 -400

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, NMAI has about the same amount of shares outstanding.
The debt/assets ratio for NMAI is higher compared to a year ago.
NMAI Yearly Shares OutstandingNMAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
NMAI Yearly Total Debt VS Total AssetsNMAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

NMAI has an Altman-Z score of 1.22. This is a bad value and indicates that NMAI is not financially healthy and even has some risk of bankruptcy.
NMAI has a debt to FCF ratio of 7.25. This is a slightly negative value and a sign of low solvency as NMAI would need 7.25 years to pay back of all of its debts.
A Debt/Equity ratio of 0.46 indicates that NMAI is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 7.25
Altman-Z 1.22
ROIC/WACCN/A
WACCN/A
NMAI Yearly LT Debt VS Equity VS FCFNMAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.06 indicates that NMAI may have some problems paying its short term obligations.
A Quick Ratio of 0.06 indicates that NMAI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
NMAI Yearly Current Assets VS Current LiabilitesNMAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

NMAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.76%.
NMAI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.08% yearly.
The Revenue has decreased by -2.28% in the past year.
Measured over the past years, NMAI shows a very strong growth in Revenue. The Revenue has been growing by 99.62% on average per year.
EPS 1Y (TTM)-34.76%
EPS 3Y42.08%
EPS 5YN/A
EPS Q2Q%-39.74%
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y99.62%
Revenue growth 5YN/A
Sales Q2Q%-3.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NMAI Yearly Revenue VS EstimatesNMAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.02, which indicates a correct valuation of NMAI.
When comparing the Price/Earnings ratio of NMAI to the average of the S&P500 Index (27.67), we can say NMAI is valued rather cheaply.
Industry RankSector Rank
PE 12.02
Fwd PE N/A
NMAI Price Earnings VS Forward Price EarningsNMAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 15.35
EV/EBITDA N/A
NMAI Per share dataNMAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

NMAI has a Yearly Dividend Yield of 11.44%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.41, NMAI pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.44%

5.2 History

NMAI has been paying a dividend for over 5 years, so it has already some track record.
The dividend of NMAI decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NMAI Yearly Dividends per shareNMAI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

152.78% of the earnings are spent on dividend by NMAI. This is not a sustainable payout ratio.
DP152.78%
EPS Next 2YN/A
EPS Next 3YN/A
NMAI Yearly Income VS Free CF VS DividendNMAI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 50M -50M 100M -100M
NMAI Dividend Payout.NMAI Dividend Payout, showing the Payout Ratio.NMAI Dividend Payout.PayoutRetained Earnings

More info and screens

NUVEEN MULTI-ASSET INCOME

NYSE:NMAI (9/29/2025, 4:15:01 PM)

12.86

+0.05 (+0.39%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners20.78%
Inst Owner Change-3.26%
Ins OwnersN/A
Ins Owner Change0%
Market Cap429.91M
AnalystsN/A
Price TargetN/A
Short Float %0.16%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 11.44%
Yearly Dividend1.67
Dividend Growth(5Y)N/A
DP152.78%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-15 2025-09-15 (0.126)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.02
Fwd PE N/A
P/S 14.82
P/FCF 15.35
P/OCF 15.35
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)1.07
EY8.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.84
FCFY6.51%
OCF(TTM)0.84
OCFY6.51%
SpS0.87
BVpS13.16
TBVpS13.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.54%
ROE 8.18%
ROCE 2.19%
ROIC 1.51%
ROICexc 1.51%
ROICexgc 1.51%
OM 42.38%
PM (TTM) 124.14%
GM 45.28%
FCFM 96.55%
ROA(3y)-2.34%
ROA(5y)N/A
ROE(3y)-4.18%
ROE(5y)N/A
ROIC(3y)1.63%
ROIC(5y)N/A
ROICexc(3y)1.63%
ROICexc(5y)N/A
ROICexgc(3y)1.63%
ROICexgc(5y)N/A
ROCE(3y)2.34%
ROCE(5y)N/A
ROICexcg growth 3Y88.09%
ROICexcg growth 5YN/A
ROICexc growth 3Y88.12%
ROICexc growth 5YN/A
OM growth 3Y-13.98%
OM growth 5YN/A
PM growth 3Y-29.29%
PM growth 5YN/A
GM growth 3Y-15.38%
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 7.25
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.23
Cash Conversion N/A
Profit Quality 77.78%
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 1.22
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.76%
EPS 3Y42.08%
EPS 5YN/A
EPS Q2Q%-39.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y99.62%
Revenue growth 5YN/A
Sales Q2Q%-3.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.24%
EBIT growth 3Y71.72%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.82%
FCF growth 3Y65.03%
FCF growth 5YN/A
OCF growth 1Y-72.82%
OCF growth 3Y65.03%
OCF growth 5YN/A